Home > Category > Signaling Pathways > Immunology & Inflammation > CD markers > Anti-Human CD3xCD19 Bispecific Antibody(Blinatumomab; Blincyto; MT103; MEDI-538; MEDI 538; Anti-human CD3 CD19; Human CD3 CD19 bispecific)

Anti-Human CD3xCD19 Bispecific Antibody(Blinatumomab; Blincyto; MT103; MEDI-538; MEDI 538; Anti-human CD3 CD19; Human CD3 CD19 bispecific)

ChemLeader 95+%

Catalog No：CLA1082 CAS No.：853426-35-4 MDLNo： Formula： MW：

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
1 mg	3-5days	$1500.00	Visible after login	- +
5 mg	3-5days	$4366.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Anti-Human CD3xCD19 Bispecific Antibody(Blinatumomab; Blincyto; MT103; MEDI-538; MEDI 538; Anti-human CD3 CD19; Human CD3 CD19 bispecific)
CAS	853426-35-4
Storage condition	Sealed and Store at -80°C. Aliquots should be stored at the same temperature after first use to avoid freeze-thaw cycles

Product details

Blinatumomab (Anatumomab) is a bispecific monoclonal antibody which can specifically targets the CD19 antigen present on B cells. Blinatumomab can be used for the research of acute lymphoblastic leukemia.

Related literature

The establishment and application of CD3E humanized mice in immunotherapy[J]

PMID: 35570001 PMCID: PMC9671771 DOI: 10.1538/expanim.22-0012

Read more

Blinatumomab versus Chemotherapy for Advanced Acute Lymphoblastic Leukemia.

PMID: 28249141 PMCID: PMC5881572 DOI: 10.1056/NEJMoa1609783

Read more

Blinatumomab, a Bi-Specific Anti-CD19/CD3 BiTE(®) Antibody for the Treatment of Acute Lymphoblastic Leukemia: Perspectives and Current Pediatric Applications.

PMID: 24744989 PMCID: PMC3978294 DOI: 10.3389/fonc.2014.00063

Read more

Related

Sorry, no related items

History

Azeliragon (TTP488)

603148-36-3 98+%

Anti-Human CD3xCD19 Bispecific Antibody(Blinatumomab; Blincyto; MT103; MEDI-538; MEDI 538; Anti-human CD3 CD19; Human CD3 CD19 bispecific)

853426-35-4 95+%

Sapropterin Dihydrochloride | (6R)-5,6,7,8-Tetrahydro-L-biopterin Dihydrochloride

69056-38-8 98+%

Virgaureagenin G | Polygalacic acid

22338-71-2 98+%

(R)-Sulforaphane (Synonyms: L-Sulforaphane; (R)-1-Isothiocyanato-4-(methylsulfinyl)butane; 4-Methylsulfinylbutyl isothiocyanate)

142825-10-3 95+%

Cilofexor(GS-9674)

1418274-28-8 98+%

Subelliptenone G | 1,4,5-Trihydroxyxanthone

162473-22-5 98+%

26652-12-0 98+%

Apigenin-7-glucoside